Results for tag: "Lumbar Spondylolisthesis Drug"

The Lumbar Spondylolisthesis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat lumbar spondylolisthesis, a condition in which one vertebra slips forward over another. These drugs are used to reduce pain, improve mobility, and reduce the risk of further damage to the spine. Common treatments include non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and corticosteroids. In some cases, surgery may be necessary. The companies in the Lumbar Spondylolisthesis Drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Johnson & Johnson. Other companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more